Suchergebnisse - "Jung, Kyung Hae"

PubPharm (369)

1

TROPION-Breast01 : Datopotamab deruxtecan vs chemotherapy in pre-treated inoperable or metastatic HR+/HER2- breast cancer

enthalten in: Future oncology (London, England) | 2024

von Bardia, A. | Jhaveri, K. | Kalinsky, K. | +21

2

A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15)

enthalten in: Therapeutic advances in medical oncology | 2024

von Baek, S. | Jeong, J. | Jung, K. | +25

3

Pemetrexed plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer (KCSG-BR15-17) : A randomized, open-label, multicenter, phase II trial

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Lee, D. | Jung, K. | Lee, K. | +16

4

Development of DHES0815A; a novel HER2-directed antibody-drug conjugate comprised of a reduced potency mono-alkylating agent linked to a domain I binding HER2 antibody

enthalten in: ResearchSquare.com | 2024

von Lewis, G. | Li, G. | Guo, J. | +27

5

The HER2-directed antibody-drug conjugate DHES0815A in advanced and/or metastatic breast cancer : preclinical characterization and phase 1 trial results

enthalten in: Nature communications | 2024

von Lewis, G. | Li, G. | Guo, J. | +28

6

Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors : Primary Results From the DESTINY-PanTumor02 Phase II Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Meric-Bernstam, F. | Makker, V. | Oaknin, A. | +15

CommentIn: Cancer Discov. 2023 Dec 12;13(12):OF10. - PMID 37888905

7

21-gene expression assay and clinical outcomes of premenopausal patients with hormone receptor-positive breast cancer

enthalten in: International journal of cancer | 2024

von Hyung, J. | Lee, S. | Kim, J. | +12

8

TROPION-Breast02 : Datopotamab deruxtecan for locally recurrent inoperable or metastatic triple-negative breast cancer

enthalten in: Future oncology (London, England) | 2023

von Dent, R. | Cescon, D. | Bachelot, T. | +9

9

Efficacy of Limited Dose Modifications for Palbociclib-Related Grade 3 Neutropenia in Hormone Receptor-Positive Metastatic Breast Cancer

enthalten in: Cancer research and treatment | 2023

von Kim, S. | Kim, M. | Park, S. | +14

10

Randomized phase III trial of a neoadjuvant regimen of four cycles of adriamycin plus cyclophosphamide followed by four cycles of docetaxel (AC4-D4) versus a shorter treatment of three cycles of FEC followed by three cycles of docetaxel (FEC3-D3) in node-positive breast cancer (Neo-shorter; NCT02001506)

enthalten in: Breast cancer research and treatment | 2023

von Hwang, I. | Kim, J. | Jeong, J. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[37]